GENE ANALYSIS CFTR CYSTIC FIBROSIS

Gene Analysis CFTR Cystic Fibrosis is a specialized molecular genetic test used to identify mutations in the CFTR (Cystic Fibrosis Transmembrane Conductance Regulator) gene. Mutations in this gene are responsible for Cystic Fibrosis (CF), an inherited genetic disorder that affects the lungs, pancreas, digestive system, and other organs. The test helps diagnose cystic fibrosis, identify carriers, and support genetic counseling and family planning decisions.

Cystic fibrosis is an autosomal recessive disorder that occurs when an individual inherits abnormal CFTR gene copies from both parents. Early detection of CFTR mutations allows timely diagnosis, appropriate medical management, and informed reproductive decision-making for affected families.

Benefits of the Test

• Accurately detects CFTR gene mutations.
• Supports diagnosis of cystic fibrosis.
• Identifies carrier status in asymptomatic individuals.
• Assists in family planning and genetic counseling.
• Supports prenatal and reproductive risk assessment.
• Provides reliable molecular genetic information.
• Helps evaluate unexplained respiratory and digestive symptoms.
• Supports personalized clinical management.

Why Doctors Recommend This Test

Doctors recommend CFTR Gene Analysis for individuals with suspected cystic fibrosis, recurrent respiratory infections, chronic lung disease, pancreatic insufficiency, unexplained digestive disorders, infertility evaluation, family history of cystic fibrosis, and carrier screening before pregnancy.

The test helps identify disease-causing mutations and provides important information regarding inherited genetic risk.

Preparation Before Test

• No fasting is required.
• A blood sample or buccal swab specimen may be collected.
• Provide relevant medical and family history.
• Inform your doctor about previous genetic testing results if available.
• Genetic counseling may be recommended before and after testing.
• Follow all specimen collection instructions carefully.

Normal Reporting Time

Most CFTR Gene Analysis reports at Focus Diagnostics are initiated within 2–3 hours for specimen processing and molecular workflow setup. Comprehensive genetic analysis, variant interpretation, quality validation, and final reporting generally require several working days depending on testing methodology and laboratory protocols.

Who Should Take This Test?

This test may be recommended for:

• Individuals with suspected cystic fibrosis.
• Children with recurrent respiratory infections.
• Patients with chronic lung disease.
• Individuals with pancreatic insufficiency.
• Couples planning pregnancy.
• People with a family history of cystic fibrosis.
• Individuals seeking carrier screening.
• Patients referred for genetic counseling and evaluation.

Detailed Information

The CFTR gene provides instructions for producing a protein that regulates the movement of chloride and water across cell membranes. When mutations occur in this gene, the resulting protein may function improperly or be absent altogether. This leads to the production of thick, sticky mucus that can accumulate in various organs, particularly the lungs and digestive tract.

Cystic fibrosis is one of the most common inherited genetic disorders worldwide. Symptoms may include chronic cough, recurrent respiratory infections, breathing difficulties, poor growth, digestive problems, malabsorption, pancreatic dysfunction, and infertility in some individuals. The severity of symptoms can vary depending on the specific mutations present.

CFTR Gene Analysis uses advanced molecular genetic techniques to identify disease-causing mutations within the CFTR gene. Hundreds of different CFTR mutations have been identified, with some causing classic cystic fibrosis and others associated with milder or atypical disease presentations.

The test is valuable not only for diagnosing affected individuals but also for identifying carriers who may pass the mutation to their children. Carrier screening is especially important for couples planning a family, as two carrier parents have a 25% chance of having a child affected by cystic fibrosis with each pregnancy.

Genetic testing may also assist in evaluating infertility, recurrent sinus disease, unexplained bronchiectasis, and certain CFTR-related disorders. The results can guide medical management, therapeutic decisions, and long-term monitoring strategies.

Results should always be interpreted in conjunction with clinical findings, sweat chloride testing, family history, imaging studies, and genetic counseling recommendations. Additional molecular studies may be required in complex cases.

At Focus Diagnostics, CFTR Gene Analysis testing is performed using advanced molecular genetics platforms, validated mutation detection methodologies, and stringent quality assurance standards to provide accurate, reliable, and clinically meaningful genetic results.